Not yet a member ?

Constitutive Assembly

 

 

Bone Marrow Adiposity Society (BMAS)

Minutes of the

CONSTITUTIVE ASSEMBLY

 

Lausanne September 1st 2017


Table of Contents

  • Abbreviations
  • CONTEXT
  • BACKGROUND
  • STATUTES: AIMS / GENERAL ASSEMBLY/ EXECUTIVE BOARD / SCIENTIFIC BOARD  / PROCEDURE FOR CANDIDATURES TO THE BOARDS / LEGAL STATUS and ORGANISATION of the SOCIETY
  • LOCATION OF UPCOMING BMA MEETINGS
  • WORKING GROUPS

 

 

 

Abbreviations:

BMA: Bone Marrow Adiposity

BMAS: Bone Marrow Adiposity Society

CA: Constitutive Assembly

GA: General Assembly

EB: Executive Board

SB: Scientific Board


 

Context

The CA was held in Lausanne, in the amphitheater of the Olympic Museum, during the BMA2017 meeting. The CA was mainly led by Olaia Naveiras, organizer of the meeting, with the help of William Cawthorn, Pierre Hardouin and Bram van der Eerden.

The CA started at 12:15 and ended at 13:00. It was included in the program of the meeting “An International Society for BMA research: Constitutive Assembly » (Friday September 1st, 2017, 12:15-13:00).

The CA had been announced the day before to introduce the points that would be discussed, and all participants of BMA2017 were invited to the CA. This announcement was also included in the official program of the meeting “An International Society for BMA Research: Introduction”  (Thursday August 31st, 2017, 14:00-14:30). It was specified that all persons registered for the BMA2017 meeting were invited and will constitute the GA.

 

BACKGROUND

Opportunity. The creation of a scientific society dedicated to bone marrow adiposity (BMA) was envisioned as early as 2015. The question was posed during the final discussion of the 1st BMA meeting in Lille (28-29 August, 2015). It was evoked again during the 2nd BMA meeting in Rotterdam (25-26 August, 2016).

Preparative work.

  • BoneAHeaD group (“Bone Adiposity in Health and Diseases”). At the end of 2015 a first group was formed (BoneAHeaD group)  coordinated by Pierre Hardouin and funded by the French Research Agency, with the goal of building a European network and applying to international funding calls. The main organizers of the three BMA meetings were included in this group. It is composed of: William Cawthorn (Edinburgh), Christophe Chauveau (Boulogne), Eleni Douni (Athens), Claire Edwards (Oxford), Pierre Hardouin (Boulogne), Olaia Naveiras (Lausanne), Guillaume Penel (Lille), Antonella Poloni (Ancone), Mara Riminucci (Roma), Jeroen van de Peppel (Rotterdam) and Bram van der Eerden (Rotterdam). The last meeting of the group took place in March 2017 in Boulogne-sur-Mer, and a session was devoted to the modalities of creating an international society.
  • CA preparatory meeting. This meeting was organized by Olaia Naveiras at EPFL (Ecole Polytechnique Fédérale de Lausanne) and took place on Wednesday September 30th, 2017 (15:30 – 20:00). The following people were invited to this meeting: members of the BoneAHead group, invited speakers of the 3 BMA meetings (BMA2015, BMA2016 and BMA2017) and other researchers having expressed an interest in a BMA international society. Invitees to the preparatory meeting were encouraged to share the invitation with other interested people. The purpose of this preparatory meeting was to discuss a pre-proposal (including the name, aims, statutes and organization of the society) and to discuss the possible options, in order to present a consensus proposal at the CA.

It is the proposal resulting from this preparatory work that was presented by Olaia Naveiras at the CA.

During this presentation she evoked the spirit of consensus that animates the group – “We respect diversity of opinion,but ultimately we speak with one voice” – and she illustrated this spirit with an image of the Olympic flame permanently ignited at the entrance of the museum.

 

 

STATUTES

 

Name of the Society

Bone Marrow Adiposity Society

Aims of the Society

Advancement of knowledge on BMA, through:

1) Organization of the BMA meetings

2) Research and Training

  • Training of young researchers
  • Data sharing
  • Establishing of common research standards
  • Foster collaborations (e.g. collective grant writing)

3) Public engagement

  • Advocacy and outreach
  • Working with other societies

4) Any other means decided by the society to promote the aims of BMAS

 

Voting on the name and aims of the society: unanimous approval.

General Assembly

The GA is held at least once a year. It is composed of all active members of the society. The regular GA is organized during the scientific BMA meeting. An exceptional GA may be decided upon by the president of the executive board, or on written request of at least 30 members, or a third of the members. The agenda must be sent to the members by email at least 15 days prior to the GA.

Composition of the GA :

  • All BMA 2017 attendees will automatically become BMAS members (no fee for 2017).
  • Non-attendees can join for annual fees (20 euros for 2018). 

  • Membership will be renewed upon registration to BMA 2018 for the same fee (20 euros). 

  • Members will benefit from a reduced registration fee for the annual meetings. 

  • Presence at the GA is required for voting (procurements/electronic vote may be approved by the GA at a later date, upon consolidation of the society)
  • Members of the EB cannot be simultaneously be members of the SB. 


Missions of the  GA: 
          

  • To elect the EB (members of the EB cannot be simultaneously be members of the SB)
  • To approve the minutes of the previous GA 

  • To validate the actions of the EB 

  • To approve the financial accounts 

  • To decide the location of the future BMA meetings 


 

 

 

Executive Board (EB)

Composition of the EB:

  • Six to 12 members, elected for 3 years (twice max), striving for demographic and
geographical diversity 

  • At least: a president, vice-president (not from the same country as the president), secretary, treasurer, young
investigator representative, and a webmaster 

  • « Founders’ Executive Board » (8 members) to receive candidatures for the 2018 
definitive EB

Missions of the EB:

o To run the society


o To propose meeting locations

o To conduct the GA


o To designate the SB

 

Founders’ EB:

  • Pierre Hardouin -> President
  • Olaia Naveiras -> Vice-president
  • William Cawthorn -> Secretary
  • Bram van der Eerden -> Treasurer
  • Eleni Douni
  • Claire Edwards
  • Antonella Poloni
  • Mara Riminucci

 

 

 

 

Scientific Board (SB)

Composition of the SB :

  • Ten to 14 members striving for demographic & geographical diversity
  • Renewal of 1/3 every 2 years (i.e. each member will serve 6 years; this will be shorter for 2018 SB members)
  • It is recommended for the president of the local organizing committee of the next BMA meeting(s) to be an SB member


Missions of the SB:

– To score the abstracts of the meeting


– To select oral communications


– To select scientific prizes


– To write (with aim to publish) a report of the meeting (in collaboration with the local organizing committee)

– Any other scientific missions decided by the society

 

Founders’ SB:

  • Local committee 2018:
    • Christophe Chauveau
    • Guillaume Penel
  • Local committee 2019:

Moustapha Kassem

Ad hoc members as per candidature letter

  • Boneahead member :

Jeroen van de Peppel

Procedure for candidature to the EB and SB

Procedure to elect the 2018 definitive EB and SB:

  • Candidature letters from any member could be sent to the « Founder’s Executive Board » from December 2017
  • Ad hoc EB positions required for a functional board (e.g. webmaster…) will be incorporated during 2018 and voted in the 2018 GA.

 

Legal status and organization of the Society

Criteria: To fit with the aims and rules of the society ; To be flexible and simple; To allow international members (including the president).

OPTIONS: 1) French 1901 Association 2) Swiss statutes
3) British statutes
4) Other

A decision will be taken by the Founder’s EB upon further legal advice. The GA mandates the EB to deposit the statutes according to the principles mentioned.

 

Voting on the boards and status: unanimous approval.

 

 

Location of upcoming BMA meetings

  • 2018: Lille, France (Christophe Chauveau and Guillaume Penel)

  • 2019: Odense, Denmark 
(Moustapha Kassem)

Voting: unanimous approval.

2020 onwards:
to be voted at the 2018 GA and so forth from candidatures submitted to the EB

The suggested possibility that a NorthAmerican edition takes place every X number of years in association with the ASBMR will be investigated.

 

WORKING GROUPS

This part was mainly led by Bram van der Eerden.

Three working groups are already decided:

Nomenclature

– Methodologies

– Biobanking

 

and three others are planned:

– Public Engagement

– Data Repositories

– Sponsorship

 

To join any of the workgroups, attendees at the GA were asked to contact

  • W.Cawthorn@ed.ac.uk

  • b.vandereerden@erasmusmc.nl

 

Attendees:

 

Nathalie Al Rassy

Ulco University, Boulogne-sur-Mer , France

 

Thomas Ambrosi

German Institute of Human Nutrition, Nuthetal, Germany    

 

Camille Attane          

University of Toulouse, Toulouse, France    

 

Sammy Badr 

University of Lille, Lille, France         

 

Sarah Beck-Cormier

INSERM, Nantes, France

 

Kerensa Beekman

VU University Medical Center, Amsterdam, Netherlands

 

Vasco Campos

EPFL, Lausanne, Switzerland

 

William Cawthorn    

University of Edinburgh, Edinburgh, UK

 

Christophe Chauveau

Ulco University, Boulogne-sur-Mer, France

 

David Benson Chou

Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts, USA

 

Aline Clabaut 

Ulco University, Boulogne-sur-Mer, France

 

Alessandro Corsi

Sapienza University of Rome, Rome, Italy

 

Xavier Coutel

University of Lille, Lille, France

 

Clarissa Craft

Washington University, St. Louis, Missouri, USA

 

Eleni Douni

University of Athens, Athens, Greece

 

Micha Drukker

Helmholtz Institute, Munich, Germany

 

James Edwards

University of Oxford, Oxford, UK

 

Claire Edwards

University of Oxford, Oxford, UK

 

Bernhard Fasching

Endogena Therapeutics inc., Zurich, Switzerland 

 

William Ferris 

Stellenbosch University, Cape Town, Western Cape, South Africa

 

Angelica Giuliani

Università Politecnica delle Marche, Ancona, Italy

 

Louise Grahnemo

University of Gothenburg, Gothenburg, Sweden

 

Pierre Hardouin

Ulco University, Boulogne-sur-Mer, France

 

Tanja Hausherr

EPFL, Lausanne, Switzerland         

 

Mark Horowitz

Yale University school of Medicine, New Haven, Connecticut, USA

 

Xavier Houard

University Pierre and Marie Curie, Paris, France

 

Moustapha Kassem

University Hospital of Odense, Odense, Denmark

 

Greet Kerckhofs

KU Leuven, Leuven, Belgium

 

Thibaut Klein

Universität Basel, Basel, Switzerland

 

Rosella Labella

Sapienza University of Rome, Rome, Italy

 

Marie Hélène Lafage-Proust

University of Lyon, Saint-Etienne, France

 

Beata Lecka-Czernik

University of Toledo College of Medicine, Toledo, Ohio, USA

 

Kaiyan Liu

Peking University Institute of Hematology, Beijing, China

 

Domenico Mattiucci

Università Politecnica Delle Marche, Ancona, Italy

 

Maria Moreno-Aliaga

University of Navarra, Pamplona, Spain

 

Emma Morris

University of Oxford, Oxford, UK

 

Teruyo Nakatani

NYU College of Dentistry, New York City, USA

 

Olaia Naveiras

EPFL, Lausanne, Switzerland

 

Biagio Palmisano

Sapienza University of Rome, Rome, Italy

 

Guillaume Penel

University of Lille, Lille, France

 

Alessia Perino

EPFL, Lausanne,Switzerland

 

Francoise Pflumio

INSERM, Fontenay-aux-Roses, France

 

Domenico Raimondo

Sapienza University of Rome, Rome, Italy

 

Benjamin Rappaz

R&D and marketing, Lausanne, Switzerland

 

Jaime Reina

Sysmex,Yverdon-les-Bains, Switzerland

 

Laurent Renou

IRCM, Montpellier, France

 

Mara Riminucci

Sapienza University of Rome, Rome, Italy

 

Maria Rita Rippo

Università Politecnica delle Marche, Ancona, Italy

 

Azaam Samad

Taylor & Francis, San Diego, USA

 

Erica Scheller

Washington University School of Medicine, Saint Louis, Missouri, USA

 

Tim Schulz

German Institute of Human Nutrition, Nuthetal, Germany

 

Frederica Schyrr

EPFL, Lausanne, Switzerland

 

Aneka Sowman

Univeristy of Oxford, Oxford, UK

 

Karla Suchacki

University of Edinburgh, Edinburgh, UK

 

Shanti Sutterlin

EPFL, Lausanne, Switzerland

 

Naveed Tavakol

EPFL, Lausanne, Switzerland

 

Michaela Tencerova (Short Oral 17, O17)

University of Southern Denmark, Odense, Denmark

 

Josefine Tratwal

EPFL, Lausanne, Switzerland

 

Bram Van der Eerden

Erasmus MC, Rotterdam, Netherlands

 

Andre van Wijnen

Mayo Clinic, Rochester, Minnesota, USA

 

Virag Vas

Hungarian Academy of Sciences Budapest, Hungary

 

Annegreet Veldhuis-Vlug

Academic Medical Center Amsterdam, Amsterdam, Netherlands         

 

Anne Wilson

University of Lausanne, Lausanne, Switzerland

 

Gina Woods

University of California, San Diego, California, USA

 

Laura Wright

Indiana University Indianapolis, Indiana, USA

 

Natalia Zapata

University Pierre and Marie Curie, Paris, France

 

Bo Zhou

University of Chinese Academy of Sciences, Shanghai, China

 

Gabriele Zuchtriegel

University Children Hospital of Zurich, Zurich, Switzerland